vs
Side-by-side financial comparison of Hyperfine, Inc. (HYPR) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.
Hyperfine, Inc. is the larger business by last-quarter revenue ($5.3M vs $5.0M, roughly 1.1× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -111.7%, a 106.1% gap on every dollar of revenue. On growth, Hyperfine, Inc. posted the faster year-over-year revenue change (128.0% vs -1.9%). cbdMD, Inc. produced more free cash flow last quarter ($-977.3K vs $-5.3M). Over the past eight quarters, Hyperfine, Inc.'s revenue compounded faster (26.7% CAGR vs 7.1%).
Hyperfine, Inc. develops and commercializes innovative portable low-field magnetic resonance imaging (MRI) systems for medical diagnostic use. Its solutions deliver accessible, cost-effective imaging for healthcare providers across acute care, rural clinics, pediatric care, and other underserved clinical settings worldwide.
cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.
HYPR vs YCBD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.3M | $5.0M |
| Net Profit | $-5.9M | $-283.1K |
| Gross Margin | 50.9% | 59.8% |
| Operating Margin | -144.9% | -5.7% |
| Net Margin | -111.7% | -5.6% |
| Revenue YoY | 128.0% | -1.9% |
| Net Profit YoY | 43.1% | -1975.7% |
| EPS (diluted) | $-0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.3M | $5.0M | ||
| Q3 25 | $3.4M | $4.7M | ||
| Q2 25 | $2.7M | $4.6M | ||
| Q1 25 | $2.1M | $4.7M | ||
| Q4 24 | $2.3M | $5.1M | ||
| Q3 24 | $3.6M | $4.6M | ||
| Q2 24 | $3.6M | $5.2M | ||
| Q1 24 | $3.3M | $4.4M |
| Q4 25 | $-5.9M | $-283.1K | ||
| Q3 25 | $-11.0M | $-680.0K | ||
| Q2 25 | $-9.2M | $-895.3K | ||
| Q1 25 | $-9.4M | $-480.8K | ||
| Q4 24 | $-10.4M | $15.1K | ||
| Q3 24 | $-10.3M | $-152.8K | ||
| Q2 24 | $-10.2M | $459.7K | ||
| Q1 24 | $-9.8M | $-3.0M |
| Q4 25 | 50.9% | 59.8% | ||
| Q3 25 | 53.8% | 58.8% | ||
| Q2 25 | 49.3% | 61.5% | ||
| Q1 25 | 41.3% | 62.3% | ||
| Q4 24 | 35.6% | 66.5% | ||
| Q3 24 | 52.4% | 53.9% | ||
| Q2 24 | 49.7% | 65.8% | ||
| Q1 24 | 41.1% | 59.0% |
| Q4 25 | -144.9% | -5.7% | ||
| Q3 25 | -259.5% | -14.5% | ||
| Q2 25 | -355.9% | -19.6% | ||
| Q1 25 | -510.2% | -10.2% | ||
| Q4 24 | -463.8% | -1.7% | ||
| Q3 24 | -300.9% | -6.9% | ||
| Q2 24 | -298.7% | -7.4% | ||
| Q1 24 | -323.2% | -35.4% |
| Q4 25 | -111.7% | -5.6% | ||
| Q3 25 | -320.6% | -14.4% | ||
| Q2 25 | -342.2% | -19.4% | ||
| Q1 25 | -440.7% | -10.1% | ||
| Q4 24 | -447.7% | 0.3% | ||
| Q3 24 | -283.4% | -3.4% | ||
| Q2 24 | -279.7% | 8.9% | ||
| Q1 24 | -298.9% | -68.8% |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $-0.12 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.14 | — | ||
| Q2 24 | $-0.14 | $-0.15 | ||
| Q1 24 | $-0.14 | $-1.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $35.1M | $3.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $41.0M | $9.0M |
| Total Assets | $55.3M | $11.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.1M | $3.4M | ||
| Q3 25 | $21.6M | $2.3M | ||
| Q2 25 | $25.4M | $1.1M | ||
| Q1 25 | $33.1M | $1.8M | ||
| Q4 24 | $37.6M | $2.0M | ||
| Q3 24 | $45.8M | $2.5M | ||
| Q2 24 | $53.8M | $2.4M | ||
| Q1 24 | $63.2M | $2.1M |
| Q4 25 | $41.0M | $9.0M | ||
| Q3 25 | $26.9M | $7.2M | ||
| Q2 25 | $35.1M | $6.1M | ||
| Q1 25 | $43.1M | $665.8K | ||
| Q4 24 | $49.0M | $1.8M | ||
| Q3 24 | $58.3M | $2.0M | ||
| Q2 24 | $66.8M | $3.0M | ||
| Q1 24 | $75.6M | $3.1M |
| Q4 25 | $55.3M | $11.8M | ||
| Q3 25 | $41.5M | $10.4M | ||
| Q2 25 | $45.2M | $9.9M | ||
| Q1 25 | $53.4M | $10.9M | ||
| Q4 24 | $58.9M | $11.5M | ||
| Q3 24 | $69.4M | $10.6M | ||
| Q2 24 | $76.6M | $13.8M | ||
| Q1 24 | $85.4M | $14.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.2M | $-812.5K |
| Free Cash FlowOCF − Capex | $-5.3M | $-977.3K |
| FCF MarginFCF / Revenue | -99.6% | -19.5% |
| Capex IntensityCapex / Revenue | 1.2% | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | $-2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.2M | $-812.5K | ||
| Q3 25 | $-5.6M | $-240.7K | ||
| Q2 25 | $-7.9M | $-704.2K | ||
| Q1 25 | $-9.2M | $-189.5K | ||
| Q4 24 | $-8.4M | $-317.9K | ||
| Q3 24 | $-8.5M | $167.4K | ||
| Q2 24 | $-9.4M | $289.8K | ||
| Q1 24 | $-12.5M | $-704.1K |
| Q4 25 | $-5.3M | $-977.3K | ||
| Q3 25 | $-5.7M | $-243.6K | ||
| Q2 25 | $-8.4M | $-705.7K | ||
| Q1 25 | $-9.7M | $-205.0K | ||
| Q4 24 | $-8.4M | $-482.3K | ||
| Q3 24 | $-8.7M | $157.4K | ||
| Q2 24 | $-9.5M | — | ||
| Q1 24 | $-12.7M | $-708.7K |
| Q4 25 | -99.6% | -19.5% | ||
| Q3 25 | -166.2% | -5.2% | ||
| Q2 25 | -312.7% | -15.3% | ||
| Q1 25 | -454.9% | -4.3% | ||
| Q4 24 | -360.4% | -9.4% | ||
| Q3 24 | -238.2% | 3.5% | ||
| Q2 24 | -260.4% | — | ||
| Q1 24 | -384.1% | -16.2% |
| Q4 25 | 1.2% | 3.3% | ||
| Q3 25 | 3.8% | 0.1% | ||
| Q2 25 | 19.3% | 0.0% | ||
| Q1 25 | 22.1% | 0.3% | ||
| Q4 24 | 0.3% | 3.2% | ||
| Q3 24 | 4.4% | 0.2% | ||
| Q2 24 | 2.0% | 0.0% | ||
| Q1 24 | 4.4% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -21.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HYPR
| Products | $4.9M | 92% |
| Other | $436.0K | 8% |
YCBD
| Sales Channel Directly To Consumer | $3.6M | 72% |
| Sales Channel Through Intermediary | $1.4M | 28% |
